Article PDF
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Biographical Sketch Hou YunDe, member and former vice president of the Chinese Academy of Engineering, was born in Changzhou, Jiangsu Province on July 13, 1929. He is a research fellow of the National Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention and director of the National Engineering Research Center for Viro Bio Technology, and holds the position of chief engineer of a major science and technology project titled “Prevention and Treatment of AIDS and Viral Hepatitis and Other Major Infectious Diseases”. During the pandemic outbreak of the new H1N1 flu in 2009, as director of the Expert Committee of the Defense and Control Mechanism, he achieved success in the intervention of the flu, which is unprecedented in the human history and has been internationally recognized. Since 1986, he has been elected three times as chief scientist of the National High Technology Research and Development Program of China in the area of biotechnology. He has made outstanding achievements in molecular virology, genome project interferon, and control and prevention of major infectious diseases, and developed genome project interferon and other cytokines products, the first batch of high-tech products launched to the markets in China, among which interferon α1b is unprecedented around the globe. He has been elected twice as director of the International Society for Interferon Research. He has published more than 400 papers and seven books, won one first prize and seven second prizes of National Science and Technology Progress, 10 first prizes of Scientific and Technological Achievements of Ministry of Health, the Ho Leung Ho Lee Prize, and Medical Science Prize of China, and first won the title of Young and Middle-aged Scientists with Outstanding Contributions.
This article is published with open access at link.springer.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Hou, Y. The hepatitis B vaccine originally jointly developed by China and the US is safe and effective. Sci. China Life Sci. 57, 549–550 (2014). https://doi.org/10.1007/s11427-014-4630-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-014-4630-5